Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs

In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a multimillion dollar eClinical company. Continuing the conversation in part two, the pair explore the commercial aspects of e-clinical solutions, particularly focusing on the landscape of Decentralized Clinical Trials (DCT). The conversation centers around evolution of DCT during the pandemic, the merging of DCT with Electronic Clinical Outcome Assessments (ECOA), and the need for a hybrid approach - balancing remote and on-site research modalities. There is an emphasis on the importance of prioritizing core measurements over excessive data collection, leveraging technology for speed, scale, and access, and envisioning a future where digital transformation enhances clinical research outcomes.